Inovatyvios medicinos iniciatyva – IMI2
Konsultuoja teminės srities atstovė, NCP: dr. Edita Bagdonaitė, de810ab12859be577bed71de3254efd2">Šis el. pašto adresas yra apsaugotas nuo šiukšlių. Jums reikia įgalinti JavaScript, kad peržiūrėti jį.
IMI2
IMI2 - Call 23
Annual Work Plan 2020 (as amended by the IMI Governing Board on 19 June 2020)
IMI2 – Call 23 webinars
| Kvietimo identifikatorius ir pavadinimas | Finansavimo schemos kodas | Kvietimo paskelbimo data | Paraiškos priimamos iki (pirmojo/antrojo etapo paraiškų priėmimo data, jei taikoma dviejų pakopų schema) |
|---|---|---|---|
| IMI2-2020-20-01: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis | IMI2-RIA | 2020-01-21 | 2020-05-12/2020-11-19 |
| IMI2-2020-20-02: Innovations to accelerate vaccine development vaccine development and manufacture | IMI2-RIA | 2020-01-21 | 2020-05-12/2020-11-19 |
| IMI2-2020-20-03: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB) | IMI2-RIA | 2020-01-21 | 2020-05-12/2020-11-19 |
| IMI2-2020-20-04: Tumour plasticity | IMI2-RIA | 2020-01-21 | 2020-05-12/2020-11-19 |
| IMI2-2020-20-05: Proton versus photon therapy for oesophageal cancer - a trimodality strategy | IMI2-RIA | 2020-01-21 | 2020-05-12/2020-11-19 |
| IMI2-2020-20-06: Handling of protein drug products and stability concerns | IMI2-RIA | 2020-01-21 | 2020-05-12/2020-11-19 |
| IMI2-2020-23-01: Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework | IMI2-RIA | 2020-06-23 | 2020-09-29/2021-03-17 |
| IMI2-2020-23-02: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance | IMI2-RIA | 2020-06-23 | 2020-09-29/2021-03-17 |
| IMI2-2020-23-03: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases | IMI2-RIA | 2020-06-23 | 2020-09-29/2021-03-17 |
| IMI2-2020-23-04: Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence | IMI2-RIA | 2020-06-23 | 2020-09-29/2021-03-17 |
| IMI2-2020-23-05: Shortening the path to Rare Disease diagnosis by using newborn genetic screening and digital technologies | IMI2-RIA | 2020-06-23 | 2020-09-29/2021-03-17 |
| IMI2-2020-23-06: Behavioural Model of Factors Affecting Patient Adherence | IMI2-RIA | 2020-06-23 | 2020-09-29/2021-03-17 |
